Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
Evaluating the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
1 other identifier
interventional
150
1 country
1
Brief Summary
This research is being done to better understand the impact of the use of a specific physical activity training program (GH Method) in dialysis/kidney disease patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 22, 2019
CompletedFirst Submitted
Initial submission to the registry
April 15, 2024
CompletedFirst Posted
Study publicly available on registry
April 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 22, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
August 14, 2025
August 1, 2025
7 years
April 15, 2024
August 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Rate at which subjects will see changes in their physical abilities.
Participants will see improvements in their physical abilities after 12 months in the exercise training sessions. This will be assessed by comparing baseline, 6 months, 12 months, using a Short Physical Performance Battery test. This test requires the assessment of walking speed (time to walk 3 meters), a balance test (standing in 3 different positions for 10 seconds each-tandem, semi tandem, and side by side), and the time it takes to sit and stand 5 times in a chair (see above). Scoring is based on a scale of 0-12, lower numbers representing worse performance.
12 months
Secondary Outcomes (6)
Rate at which exercise will change body composition
12 months
Rate at which exercise will change handgrip strength.
12 months
Rate at which subjects enrolled in the exercise intervention will have an overall changed sense of well-being.
12 months
Rate at which subjects enrolled in the exercise intervention will have an overall changed in their quality of life.
12 months
Rate at which subjects enrolled in the exercise intervention will have an overall decreased change in depression.
12 months
- +1 more secondary outcomes
Study Arms (2)
Investigate the effects of an exercise intervention on clinically debilitated dialysis patients.
EXPERIMENTAL150 patients from UI Health (≥ 18 years of age), who are on dialysis, or have chronic kidney disease stage 4 (CKD 4 = GFR between 15 and 29), or have chronic kidney disease stage 5 (CKD 5 = GFR below 15) and are considered clinically debilitated by their direct healthcare professional. After the initial baseline visit, subjects will come twice weekly, for roughly 1 hour each session, for 12 months (96 visits total). Subjects will also come in for data collection visits at baseline (prior to starting the exercise program), 6 months, and 12 months. Each of those visits will take about 2-3 hours. All testing done in the 3 test visits will help assess the patient's cardiovascular and functional responses and/or changes to the exercise intervention.
Control
NO INTERVENTIONThe control arm will receive no exercise intervention. Subjects will also come in for data collection visits at baseline (prior to starting the exercise program), 6 months, and 12 months. Each of those visits will take about 2-3 hours. All testing done in the 3 test visits will help assess the patient's cardiovascular and functional responses.
Interventions
Participants will attend 2 muscle therapy sessions a week for 12 months, for one hour each.
Eligibility Criteria
You may qualify if:
- Clinically debilitated patients, currently on dialysis, or have CKD 4 (GFR between 15 and 29), or have CKD 5 (GFR below 15), or post- kidney transplant (for PPKT Subgroup only) as stated by patient's health care professional.
- Adequate cognitive ability to complete the questionnaires, give consent for the study and follow the physical and diet instructions
You may not qualify if:
- cardiac/pulmonary disease that contraindicate the physical training
- Unable to give consent
- Unable to travel to the training center
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois at Chicago
Chicago, Illinois, 60612, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Enrico Benedetti
University of Illinois at Chicago
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Professor and Head Department of Surgery
Study Record Dates
First Submitted
April 15, 2024
First Posted
April 18, 2024
Study Start
May 22, 2019
Primary Completion (Estimated)
May 22, 2026
Study Completion (Estimated)
May 1, 2027
Last Updated
August 14, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share